Company
United StatesBiohaven Pharmaceuticals. Inc., New Haven, CT – FDA Inspections
Inspection records and compliance data for Biohaven Pharmaceuticals. Inc. in New Haven, Connecticut. 3 FDA inspections on record, last inspected April 24, 2025.
Company Profile
This profile covers Biohaven Pharmaceuticals. Inc. based in New Haven, Connecticut, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected November 7, 2019. Last inspected April 24, 2025.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 24, 2025 | Not classified | Human Drugs | 1269430 |
| September 9, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1180548 |
| November 7, 2019 | VAI | Human Drugs · Bioresearch Monitoring | 1112681 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Biohaven Pharmaceuticals. Inc.
FEI Number
3010802167
Address
215 Church St, New Haven, Connecticut 06510, United States
Country
United States
ID: cad96470-9095-49f8-9bed-2444d3d26a63